Focal Prostate Cancer Therapy Offers Alternative to Full Surgical Removal

A major randomized trial shows that treating only the cancerous region of the prostate—rather than removing the entire gland—is a viable option for men with localized disease. The finding could reshape treatment standards and reduce side effects, potentially lowering healthcare costs while preserving quality of life for thousands of patients annually.

Originaltitel: Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer